Switch to:

Castle Biosciences EV-to-EBIT

: 81.97 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Castle Biosciences's Enterprise Value is $865.31 Mil. Castle Biosciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $10.56 Mil. Therefore, Castle Biosciences's EV-to-EBIT for today is 81.97.

NAS:CSTL' s EV-to-EBIT Range Over the Past 10 Years
Min: 16.4   Med: 45.95   Max: 81.97
Current: 81.97

16.4
81.97

During the past 3 years, the highest EV-to-EBIT of Castle Biosciences was 81.97. The lowest was 16.40. And the median was 45.95.

NAS:CSTL's EV-to-EBIT is ranked lower than
82% of the 110 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 36.87 vs. NAS:CSTL: 81.97 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Castle Biosciences's Enterprise Value for the quarter that ended in Jun. 2020 was $575.18 Mil. Castle Biosciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $10.56 Mil. Castle Biosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was 1.84%.


Castle Biosciences EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
EV-to-EBIT 0.00 0.00 51.92

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 20.71 51.92 41.87 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Castle Biosciences EV-to-EBIT Distribution

* The bar in red indicates where Castle Biosciences's EV-to-EBIT falls into.



Castle Biosciences EV-to-EBIT Calculation

Castle Biosciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=865.305/10.557
=81.97

Castle Biosciences's current Enterprise Value is $865.31 Mil.
Castle Biosciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 6.937 (Sep. 2019 ) + 2.893 (Dec. 2019 ) + 1.334 (Mar. 2020 ) + -0.607 (Jun. 2020 ) = $10.56 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences  (NAS:CSTL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Castle Biosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 ) =EBIT / Enterprise Value (Q: Jun. 2020 )
=10.557/575.184291
=1.84 %

Castle Biosciences's Enterprise Value for the quarter that ended in Jun. 2020 was $575.18 Mil.
Castle Biosciences's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was 6.937 (Sep. 2019 ) + 2.893 (Dec. 2019 ) + 1.334 (Mar. 2020 ) + -0.607 (Jun. 2020 ) = $10.56 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences EV-to-EBIT Related Terms


Castle Biosciences EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)